📰 Area Under News
Page 4 - Area Under News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Area Under. Real-time updates on events, politics, business and more.
August 28, 2023
Identification and Prediction Model of Placenta-Brain Axis Genes Associated With Neurodevelopmental Delay in Moderate and Late Preterm Children 1. This analysis of a prospective cohort of moderate and late preterm (MLPT) children found both MLPT-specific and MLPT-sex-specific neurodevelopmental delays. The gross motor and personal-social domains of development were most affected, particularly in males. 2. Two
August 9, 2023
Study Comparing 3D VECG Approach to Conventional 12L ECG Appeared in JACC: Advances, a Journal of the American College of Cardiology ...
July 30, 2023
MLB odds, predictions, and picks for Milwaukee Brewers at Atlanta Braves on July 30. MLB free pick for Brewers-Braves.
July 27, 2023
Reports positive topline data from latest pilot pharmacokinetic studyPlans to submit pivotal PK clinical study protocol to the FDA in early AugustAnticipates commencement of its definitive pivotal PK...
July 7, 2023
AI (artificial intelligence) may sound like a cold robotic system, but Osaka Metropolitan University scientists have shown that it can deliver heartwarming-;or, more to the point, "heart-warning"-;support.
June 26, 2023
/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery...
June 26, 2023
Eupraxia Pharmaceuticals Inc. announced positive results from its Phase 2b clinical trial of EP-104IAR for pain associated with knee osteoarthritis ("OA"). EP-104IAR met its primary endpoint with a clinically meaningful and statistically signifi...
May 18, 2023
Lexarias Hormone Study Shows Significant Enhancement in Oral Estradiol ...
May 18, 2023
900% and 2,000% improvements in peak bloodstream delivery using DehydraTECHKELOWNA, BC / ACCESSWIRE / May 18, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a
April 11, 2023
/PRNewswire/ -- New findings demonstrate important progress in the development of novel diagnostics for immunotherapy among other important cancer therapies,...